HK88696A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
HK88696A
HK88696A HK88696A HK88696A HK88696A HK 88696 A HK88696 A HK 88696A HK 88696 A HK88696 A HK 88696A HK 88696 A HK88696 A HK 88696A HK 88696 A HK88696 A HK 88696A
Authority
HK
Hong Kong
Prior art keywords
coating materials
agents
composition
pharmaceutical agent
pharmaceutical compositions
Prior art date
Application number
HK88696A
Other languages
English (en)
Inventor
Young W Cho
Original Assignee
Eurasiam Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurasiam Lab filed Critical Eurasiam Lab
Publication of HK88696A publication Critical patent/HK88696A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
HK88696A 1986-03-21 1996-05-23 Pharmaceutical compositions HK88696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84262586A 1986-03-21 1986-03-21

Publications (1)

Publication Number Publication Date
HK88696A true HK88696A (en) 1996-05-31

Family

ID=25287846

Family Applications (1)

Application Number Title Priority Date Filing Date
HK88696A HK88696A (en) 1986-03-21 1996-05-23 Pharmaceutical compositions

Country Status (16)

Country Link
EP (1) EP0302065B1 (xx)
JP (1) JPH01500589A (xx)
KR (1) KR900001074B1 (xx)
CN (1) CN87103560A (xx)
AT (1) ATE109659T1 (xx)
AU (1) AU608756B2 (xx)
CA (1) CA1281645C (xx)
DE (1) DE3750369T2 (xx)
FI (1) FI95538C (xx)
HK (1) HK88696A (xx)
HU (1) HU207452B (xx)
IE (1) IE65667B1 (xx)
PT (1) PT84537A (xx)
RU (1) RU1814559C (xx)
WO (1) WO1987005505A1 (xx)
ZA (1) ZA872018B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
NZ230764A (en) * 1988-09-27 1991-01-29 Takeda Chemical Industries Ltd Enteric films comprising hydroxypropylmethylcellulose phthalate, polyethylene glycol and shellac; preparation thereof
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5439967A (en) * 1991-09-17 1995-08-08 Micro Vesicular Systems, Inc. Propylene glycol stearate vesicles
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
EP0943336A1 (en) * 1996-09-04 1999-09-22 Dott Research Laboratory Peptide-containing pharmaceutical compositions for oral administration
JP2002525106A (ja) 1998-09-25 2002-08-13 グリコックス コーポレイション リミティド フルクトサミンオキシダーゼアッセイ：方法及び材料
CN1324234A (zh) 1998-09-25 2001-11-28 格利科克斯有限公司 果糖胺氧化酶,拮抗剂和抑制剂
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
AU1071200A (en) * 1998-10-19 2000-05-08 Biotech Australia Pty Limited Systems for oral delivery
US6884792B2 (en) 1999-01-08 2005-04-26 Marvin B. Bacaner Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
MXPA01007024A (es) 1999-01-08 2002-03-27 B Bacaner Marvin Composiciones y equipos novedosos de bretilio y su uso en la prevencion y el tratamiento de condiciones cardiovasculares.
CN1141974C (zh) 2000-06-07 2004-03-17 张昊 结肠定位释放的口服生物制剂
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
JP2003001090A (ja) * 2001-06-22 2003-01-07 Pauretsuku:Kk 流動層装置
JP5595626B2 (ja) * 2001-06-22 2014-09-24 株式会社パウレック コーティング装置
DK2500018T3 (en) 2002-03-08 2017-10-02 Philera New Zealand Ltd Prevention and / or treatment of cardiovascular disease and / or associated heart failure
CA2496411A1 (en) 2002-08-20 2004-03-04 Protemix Corporation Limited Dosage forms and related therapies
EP1778618B1 (en) 2004-07-19 2013-12-25 PhilERA New Zealand Limited Synthesis of triethylenetetramines
US8221747B2 (en) * 2007-02-20 2012-07-17 Aptalis Pharma Limited Stable pancreatic enzyme compositions
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
SI2621476T1 (sl) 2010-10-01 2014-12-31 Aptalis Pharma Limited Gastrorezistentne obloĹľene pankrelipazne formulacije z nizko trdnostjo
ES2558756T3 (es) 2011-08-08 2016-02-08 Aptalis Pharma Limited Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas
RU2519099C1 (ru) * 2012-11-08 2014-06-10 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Фармацевтическая композиция
ES2784227T3 (es) 2013-08-09 2020-09-23 Allergan Pharmaceuticals Int Ltd Composición de enzimas digestivos adecuada para la administración entérica
CA2947998A1 (en) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts
JP7233852B2 (ja) * 2018-04-17 2023-03-07 キョーリンリメディオ株式会社 変色が抑制された固形製剤
JP6612004B1 (ja) * 2018-07-31 2019-11-27 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
WO2020026570A1 (ja) * 2018-07-31 2020-02-06 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
WO2020026471A1 (ja) * 2018-07-31 2020-02-06 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
JP6823212B1 (ja) 2020-01-31 2021-01-27 株式会社中田製作所 スクイズ装置
WO2023017537A1 (en) 2021-08-12 2023-02-16 Celagenex Research (India) Pvt. Ltd. Oral algal oil based gastro-intestinal tract permeable peptide composition
CN114313354B (zh) * 2021-12-29 2022-11-08 江南大学 一种基于红外加热的液体微胶囊固化装置及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
GB1155036A (en) * 1966-07-08 1969-06-11 Ethan Allan Brown Injectionable Substance
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4447412A (en) * 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms

Also Published As

Publication number Publication date
CA1281645C (en) 1991-03-19
FI95538C (fi) 1996-02-26
WO1987005505A1 (en) 1987-09-24
JPH01500589A (ja) 1989-03-01
IE870696L (en) 1987-09-21
PT84537A (en) 1987-04-01
DE3750369T2 (de) 1995-05-24
AU608756B2 (en) 1991-04-18
EP0302065B1 (en) 1994-08-10
KR870008587A (ko) 1987-10-19
RU1814559C (ru) 1993-05-07
FI884291A0 (fi) 1988-09-19
HU207452B (en) 1993-04-28
AU7207387A (en) 1987-10-09
EP0302065A1 (en) 1989-02-08
IE65667B1 (en) 1995-11-15
JPH0576928B2 (xx) 1993-10-25
HUT48821A (en) 1989-07-28
EP0302065A4 (en) 1990-09-12
ATE109659T1 (de) 1994-08-15
CN87103560A (zh) 1988-05-18
ZA872018B (en) 1988-02-24
FI95538B (fi) 1995-11-15
KR900001074B1 (ko) 1990-02-26
DE3750369D1 (de) 1994-09-15
FI884291A (fi) 1988-09-19

Similar Documents

Publication Publication Date Title
HK88696A (en) Pharmaceutical compositions
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
IL77467A (en) Drug-containing aerosol formulations comprising chlorofluorocarbon propellent
CA2246289A1 (fr) Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
IE940583L (en) Topical antimicrobial pharmaceutical compositions
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
FR2610947B1 (fr) Formulations liquides d'enzymes
IT9021091A0 (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composi- zioni ottenute
RU94045129A (ru) Состав для похудения для местного применения, содержащий два типа липосом, и способ уменьшения и/или устранения полноты и/или избыточного веса
HK1005224A1 (en) Use of complex lipide as stabilizing additives in pharmaceutical formulation of digestive enzyme mixture.
AU7916798A (en) Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
EP0135171A3 (en) Pharmaceutical composition for interferon application
NZ191630A (en) Medicated animal feeds containing liver meal
AU7284098A (en) Method for preventing gastritis using amylin or amylin agonists
DE60031307D1 (de) Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
MX9300707A (es) Composiciones liposomaticas topicas que comprenden piroxicam y procedimiento para su preparacion.
FR2754715B1 (fr) Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
EP0210703A3 (en) Acylphosphorotriamides useful as lipid-altering agents
JPS5668616A (en) Preparation of antibiotic composition
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
EP0335446A3 (en) Agents for treating neoplasms

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)